What is the Novelix Pharmaceuticals Ltd share price today?

The share price of BSE:NOVELIX-X on 01 Oct 2026 (as of 15:06:27 IST) is ₹70.

What is the BSE:NOVELIX-X 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:NOVELIX-X 52 week high low range shows a high of ₹92 and a low of ₹38.

What is the Novelix Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Novelix Pharmaceuticals Ltd market cap is ₹1992900000.

What is the shareholding pattern of Novelix Pharmaceuticals Ltd Stock?

The shareholding pattern of Novelix Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 50.57% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 49.43% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Novelix Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Novelix Pharmaceuticals Ltd is 54.9008, and the Price-to-Book (PB) ratio is 1.5096, as on 01 Oct 2026.

Novelix Pharmaceuticals Share Price

64.20-1.81 (-2.74%)

+22.15% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

-2.74%

1 Week

-6.37%

1 Month

-3.07%

3 Month

-12.91%

6 Month

+17.69%

YTD

+2.52%

1 Year

+22.15%

5 Year

NA

10 Year

NA

Max

+141.26%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

58.06

58.00

54.00

50.60

49.01

High

71.00

73.90

83.99

92.00

About

Trimurthi Limited is a Public Limited Company having Registered Office situated at Hyderabad, Telangana. The company is into the business of Trading of Pharmaceuticals and related products and is into Read more

Trading

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

ADANIENT-ANSE

CPPLUS-ANSE

PREMIERENE-ANSE

AEGISLOG-ANSE

REDINGTON-ANSE

HONASA-ANSE

LLOYDSENT-ANSE

CELLO-ANSE

JSLL-ANSE

SREEL-TNSE

NOVELIX-XNSE

LTP

1W Low

1W High

Market cap (₹)

2590-17.5 (-0.67%)

2559

2634

3,53,335Cr

3890-61.15 (-1.55%)

3624.65

3947.90

47,150Cr

888.9+26.9 (3.12%)

850

894

40,334Cr

1180.25-0.6 (-0.05%)

1082

1253.90

38,645Cr

335.35-21.6 (-6.05%)

315

356.75

25,810Cr

456+8.1 (1.81%)

435.40

465.55

14,727Cr

60.57-2.14 (-3.41%)

59.72

62.86

9,182Cr

341.7-0.8 (-0.23%)

326.05

353.95

7,800Cr

343-4.7 (-1.35%)

330.20

350.05

4,225Cr

264.2+10.2 (4.02%)

248.40

271.50

607Cr

64.2-6.99 (-9.82%)

58

71

188Cr

Novelix Pharmaceuticals Share Price

64.20-1.81 (-2.74%)

+22.15% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Novelix Pharmaceuticals Share Price

64.20-1.81 (-2.74%)

+22.15% past 1 Year

Financial overview

Compounded Sales Growth

10 years36%

5 years97%

3 years232%

Last year627%

Compounded Profit Growth

10 years16%

5 years7%

3 years-

Last year712%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year22%

Return on Equity

10 years-4%

5 years-10%

3 years0%

Last year1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
36%	97%	232%	627%
16%	7%	-	712%
-	-	-	22%
-4%	-10%	0%	1%

Peer Comparison

Symbol

ADANIENT-A

CPPLUS-A

PREMIERENE-A

AEGISLOG-A

REDINGTON-A

HONASA-A

LLOYDSENT-A

CELLO-A

JSLL-A

SREEL-T

NOVELIX-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
2,590	₹353335 Cr	61.58	11.02	97.19	₹9339 Cr
3,890	₹47150 Cr	98.79	12.07	43.68	₹368 Cr
888.9	₹40334 Cr	24.22	10.2	45.28	₹1510 Cr
1,180.25	₹38645 Cr	29.01	7.42	44.04	₹898 Cr
335.35	₹25810 Cr	15.17	6.22	24.36	₹1490 Cr
456	₹14727 Cr	59.17	2.77	8.99	₹200 Cr
60.57	₹9182 Cr	81.77	0.38	0.91	₹283 Cr
341.7	₹7800 Cr	24.93	3.32	17.46	₹332 Cr
343	₹4225 Cr	17.87	5.31	23.32	₹222 Cr
264.2	₹607 Cr	18.5	3.02	14.74	₹29 Cr
64.2	₹188 Cr	51.77	0.49	1.33	₹3 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹37 Cr	₹25 Cr	₹48 Cr	₹36 Cr	₹22 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹60 L	₹84 L	₹50 L	₹93 L	₹2 Cr	₹87 L	₹43 L	₹5 L	₹7 L	₹7 L	₹9 L	₹21 L	₹47 L	₹32 L	₹12 L	₹30 L	₹24 L	₹51 L	₹18 L	₹15 L	₹32 L	₹49 L	₹99 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹27 L	₹30 L	₹12 L	₹80 L	₹54 L	₹2 Cr	₹27 L	₹24 L	₹21 L	₹21 L	₹31 L	₹31 L	₹26 L	₹58 L	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹10,000	₹0	₹0	₹3 L	₹0	₹0	₹10,000	-₹8 L	₹10 L	₹13 L	₹9 L	₹5 L	₹5 L	₹23 L	₹18 L	₹4 L	₹6 L	₹9 L	₹7 L	₹30 L	₹10 L	₹5 L	₹10 L	₹6 L	₹11 L	₹10 L	₹12 L	₹8 L	₹4 L	₹11 L	-₹30,000	₹2 L	₹90,000	-₹90,000	₹10,000	₹10,000	₹23 L	₹18 L	₹32 L	₹0	₹10 L	-₹4 L	₹3 L	₹4 L	₹5 L	-₹21 L	₹0	₹0	₹0	₹0	₹0	₹29 L	₹21 L	₹60,000	₹24 L	₹20 L
₹37 Cr	₹25 Cr	₹48 Cr	₹36 Cr	₹22 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹70 L	₹97 L	₹58 L	₹98 L	₹2 Cr	₹1 Cr	₹61 L	₹9 L	₹12 L	₹16 L	₹16 L	₹50 L	₹57 L	₹38 L	₹22 L	₹37 L	₹35 L	₹61 L	₹30 L	₹23 L	₹36 L	₹60 L	₹99 L	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹27 L	₹53 L	₹30 L	₹1 Cr	₹54 L	₹2 Cr	₹24 L	₹27 L	₹25 L	₹26 L	₹10 L	₹31 L	₹26 L	₹58 L	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr
₹36 Cr	₹24 Cr	₹47 Cr	₹36 Cr	₹22 Cr	₹21 Cr	₹5 Cr	₹4 Cr	₹1 Cr	₹69 L	₹58 L	₹1 Cr	₹2 Cr	₹1 Cr	₹55 L	₹17 L	₹18 L	₹2 Cr	₹24 L	₹23 L	₹70 L	₹3 Cr	₹27 L	₹43 L	₹42 L	₹42 L	₹32 L	₹35 L	₹32 L	₹46 L	₹98 L	₹1 Cr	₹1 Cr	₹1 Cr	₹98 L	₹15 L	₹38 L	₹31 L	₹88 L	₹53 L	₹2 Cr	₹31 L	₹21 L	₹17 L	₹19 L	₹42 L	₹14 L	₹12 L	₹48 L	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹73 L	₹18 L	₹23 L	₹13 L	₹14 L	-₹34 L	₹28 L	₹2 L	-₹6 L	-₹14 L	₹3 L	₹9 L	-₹7 L	-₹5 L	-₹2 Cr	-₹5 L	₹28 L	-₹11 L	-₹3 Cr	-₹3 L	-₹4 L	-₹4 L	₹21 L	₹80,000	-₹10 L	₹7 L	₹18 L	₹3 L	₹7 L	₹4 L	-₹1 L	₹11 L	₹16 L	₹19 L	₹3 L	₹27 L	₹4 L	-₹3 L	₹50,000	₹17 L	₹14 L	₹15 L	-₹15 L	₹24 L	₹22 L	₹18 L	₹10 L	₹22 L	₹31 L	₹27 L	₹10 L	₹27 L	₹25 L
₹12 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹10,000	₹10,000	₹20,000	₹0	₹10,000	₹20,000	₹20,000	₹20,000	₹70,000	₹0	₹0
₹1 Cr	₹1 Cr	₹1 Cr	₹72 L	₹17 L	₹21 L	₹13 L	₹13 L	-₹35 L	₹28 L	-₹4 L	-₹7 L	-₹15 L	₹1 L	₹6 L	-₹8 L	-₹6 L	-₹2 Cr	-₹8 L	₹27 L	-₹13 L	-₹3 Cr	-₹5 L	-₹7 L	-₹7 L	₹20 L	-₹1 L	-₹12 L	₹4 L	₹14 L	₹40,000	₹4 L	₹90,000	-₹6 L	₹7 L	₹12 L	₹15 L	-₹90,000	₹23 L	₹1 L	-₹6 L	-₹8 L	₹6 L	₹8 L	₹7 L	-₹32 L	₹17 L	₹14 L	₹10 L	₹3 L	₹14 L	₹24 L	₹20 L	₹2 L	₹20 L	₹19 L
₹1 Cr	₹91 L	₹1 Cr	₹53 L	₹11 L	₹18 L	₹15 L	₹13 L	-₹35 L	₹28 L	-₹3 L	-₹7 L	-₹17 L	₹1 L	₹7 L	-₹9 L	-₹6 L	-₹2 Cr	-₹1 L	₹21 L	-₹13 L	-₹3 Cr	-₹5 L	-₹6 L	-₹6 L	₹19 L	-₹1 L	-₹11 L	₹3 L	₹11 L	₹5 L	₹6 L	₹3 L	-₹8 L	₹5 L	₹10 L	₹11 L	₹60,000	₹17 L	₹1 L	-₹6 L	-₹6 L	₹1 L	₹6 L	₹5 L	-₹26 L	₹12 L	₹10 L	₹7 L	₹4 L	₹10 L	₹15 L	₹14 L	₹2 L	₹11 L	₹14 L

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹10 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr
₹8 Cr	-₹75 L	-₹90 L	-₹86 L	₹70 L	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹87 L	₹42 L	₹33 L
₹8 Cr	-₹75 L	-₹90 L	-₹86 L	₹70 L	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹87 L	₹42 L	₹33 L
₹18 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹11 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 L	₹4 L	₹0	₹8 L	₹23 L	₹20 L	₹0
-₹4 L	-₹5 L	-₹6 L	-₹7 L	-₹6 L	-₹6 L	-₹6 L	₹4 L	₹2 L	₹2 L	₹8 L	₹12 L	₹14 L	₹16 L	₹18 L	₹21 L	₹19 L	₹16 L
-₹4 L	-₹5 L	-₹6 L	-₹7 L	-₹6 L	-₹6 L	-₹6 L	₹4 L	₹2 L	₹2 L	₹8 L	₹13 L	₹18 L	₹16 L	₹25 L	₹43 L	₹39 L	₹16 L
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹9 Cr	₹30,040	₹5 L	₹0	₹1 L	₹66,894	₹10 L	₹31 L	₹0	₹0	₹0	₹5 L	₹2 L	₹2 Cr	₹8 L	₹9 L	₹30 L	₹35 L
₹0	₹71,320	₹78,450	₹81,500	₹98,000	₹1 L	₹4 L	₹7 L	₹7 L	₹8 L	₹7 L	₹11 L	₹11 L	₹3 Cr	₹15 L	₹10 L	₹3 L	₹50,750
₹37 L	₹0	₹0	₹0	₹0	₹63,870	₹4 L	₹8 L	₹5 L	₹10 L	₹10 L	₹21 L	₹20 L	₹39 L	₹48 L	₹44 L	₹36 L	₹10 L
₹10 Cr	₹1 L	₹6 L	₹81,500	₹2 L	₹3 L	₹18 L	₹47 L	₹13 L	₹17 L	₹18 L	₹37 L	₹33 L	₹5 Cr	₹71 L	₹63 L	₹69 L	₹45 L
₹27 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹13 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr
₹0	₹0	₹0	₹0	₹3 L	₹3 L	₹3 L	₹3 L	₹3 L	₹3 L	₹0	₹0	₹0	₹0	₹93,461	₹0	₹3 L	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 L	₹7 L	₹8 L	₹15 L	₹23 L	₹20 L	₹0
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr
₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹97 L	₹73 L	₹51 L
₹19 L	₹12 L	₹17 L	₹23 L	₹22 L	₹31 L	₹37 L	₹61 L	₹59 L	₹55 L	₹75 L	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹8 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹4 L	₹3 Cr	₹3 Cr	₹59 L	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹32 L	₹2 L	₹51 L	₹52 L	₹81 L	₹25 L	₹32 L
₹4 L	₹3 Cr	₹3 Cr	₹59 L	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹32 L	₹2 L	₹51 L	₹52 L	₹81 L	₹25 L	₹32 L
₹0	₹0	₹0	₹0	₹20 L	₹20 L	₹21 L	₹21 L	₹21 L	₹23 L	₹21 L	₹21 L	₹34 L	₹34 L	₹23 L	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹9 L	₹0	₹0	₹0
₹23 L	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹84 L	₹1 Cr	₹82 L	₹53 L	₹25 L	₹8 L	₹10 L	₹11 L	₹22 L	₹0	₹0	₹32 L	₹33 L	₹60 L	₹1 Cr	₹80 L	₹55 L	₹1 Cr
₹18 Cr	₹1 L	₹19 L	₹10 L	₹9 L	₹8 L	₹2 Cr	₹1 Cr	₹40 L	₹73,301	₹12 L	₹85 L	₹82 L	₹5 Cr	₹95 L	₹1 Cr	₹94 L	₹80 L
₹68 L	₹12 L	₹27 L	₹3 Cr	₹2 Cr	₹95 L	₹16 L	₹15 L	₹34 L	₹44 L	₹17 L	₹87 L	₹37 L	₹36 L	₹33 L	₹17 L	₹97 L	₹1 Cr
₹2 L	₹7 L	₹5 L	₹30 L	₹24 L	₹2 Cr	₹13 L	₹6 L	₹3 L	₹3 L	₹1 L	₹0	₹8 L	₹0	₹5 L	₹1,549	₹1,549	₹90,802
₹7 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹7 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹2 Cr
₹27 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹11 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr
₹17 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹8 Cr	₹9 Cr	₹8 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹5 Cr
₹27 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹13 Cr	₹9 Cr	₹9 Cr	₹8 Cr	₹8 Cr
₹18	₹9	₹9	₹9	₹11	₹15	₹15	₹15	₹14	₹14	₹14	₹14	₹14	₹12	₹12	₹1	₹11	₹10
₹18	₹9	₹9	₹9	₹11	₹15	₹15	₹15	₹14	₹14	₹14	₹14	₹14	₹12	₹12	₹11	₹11	₹10

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹12 L	₹2 L	-₹6 L	-₹2 Cr	-₹3 Cr	₹11 L	₹19 L	₹29 L	₹20 L	₹14 L	₹9 L	₹61 L	₹55 L	₹61 L	₹70 L	₹91 L	₹48 L	₹63 L
₹2 L	-₹27 L	-₹46 L	₹1 Cr	-₹24 L	-₹36 L	-₹7 L	₹22 L	₹24 L	₹26 L	-₹54 L	-₹61 L	-₹44 L	-₹40 L	-₹36 L	-₹28 L	-₹28 L	-₹34 L
-₹14 Cr	-₹10 L	-₹2 Cr	₹1 Cr	₹4 Cr	₹2 Cr	-₹55 L	₹66 L	-₹1 Cr	₹2 Cr	₹12 L	₹25 L	-₹3 Cr	-₹37 L	-₹44 L	-₹77 L	-₹60 L	-₹45 L
-₹14 Cr	-₹34 L	-₹2 Cr	₹59 L	₹58 L	₹1 Cr	-₹43 L	₹1 Cr	-₹1 Cr	₹2 Cr	-₹33 L	₹25 L	-₹3 Cr	-₹16 L	-₹11 L	-₹14 L	-₹40 L	-₹15 L
-₹14 Cr	-₹34 L	-₹2 Cr	₹59 L	₹58 L	₹1 Cr	-₹44 L	₹1 Cr	-₹1 Cr	₹2 Cr	-₹43 L	₹3 L	-₹3 Cr	-₹35 L	-₹59 L	-₹58 L	-₹79 L	-₹30 L
₹3 Cr	₹19 L	₹8 L	₹28 L	₹21 L	-₹42 L	₹45 L	-₹1 Cr	₹97 L	-₹2 Cr	-₹25 L	₹50 L	₹1 Cr	₹65 L	₹83 L	-₹24 L	₹44 L	₹39 L
₹11 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹1 L	-₹3 L	₹2 Cr	-₹28 L	-₹7 L	₹2 L	₹20 L	₹75 L
₹56 L	-₹16 L	-₹2 Cr	₹87 L	₹78 L	₹79 L	₹72,000	-₹19 L	-₹10 L	₹27 L	-₹69 L	₹50 L	₹1 L	₹2 L	₹17 L	-₹80 L	-₹14 L	₹84 L
₹12 L	₹27 L	₹3 Cr	₹2 Cr	₹95 L	₹16 L	₹15 L	₹34 L	₹44 L	₹17 L	₹87 L	₹37 L	₹36 L	₹33 L	₹17 L	₹97 L	₹1 Cr	₹28 L
₹68 L	₹12 L	₹27 L	₹3 Cr	₹2 Cr	₹95 L	₹16 L	₹15 L	₹34 L	₹44 L	₹17 L	₹87 L	₹37 L	₹36 L	₹34 L	₹17 L	₹97 L	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Novelix Pharmaceuticals Share Price

64.20-1.81 (-2.74%)

+22.15% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Novelix Pharmaceuticals Share Price

64.20-1.81 (-2.74%)

+22.15% past 1 Year

Shareholding summary

Promoters

54.29%

FII

0%

DII

0%

MF

0%

Others

45.71%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
54.29%	50.57%	49.43%	51.98%	53.33%	52.75%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
45.71%	49.43%	50.57%	48.02%	46.67%	47.25%

Bulk & block deals

Name

Medo Capital Services Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
03 Jul 2025	Sell	54.11 L	₹43.29	1.25 L	Bulk	0.774425	BSE

Insider trading & SAST

Client name

Vupparapalli Chandrasekhar Reddy & Others

Gattu Gnana Prakash & Others

Srinidhi Fine-Chemicals Llp & Narahari Belide

Vupparapalli Chandrasekhar

Srinidhi Fine Chemicals Llp

Narhari Belide

Neha Gattu

Srinidhi Fine- Chemicals Llp & Other

Vupparapalli Reddy & Other

Srindhi Fine Chemicals Llp & Others

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
06 Aug 2026	Promoter	Acquisition	1.29	12.75	0	—	7.75 L	09 Jul 2026	Conv. of Warrants	36,30,733	SAST	29(2)	—
06 Aug 2026	Promoter	Acquisition	0.35	2.11	0	—	1 L	09 Jul 2026	Conv. of Warrants	6,00,000	SAST	29(2)	—
06 Aug 2026	Other	Acquisition	2.93	39.35	0	—	21 L	09 Jul 2026	Conv. of Warrants	1,12,02,000	SAST	29(2)	—
13 Jul 2026	Promoter	Acquisition	4.399659	10.21	1.55 Cr	₹20	7.75 L	09 Jul 2026	Allotment	29,05,733	Insider Trading	—	Equity
13 Jul 2026	Promoter	Acquisition	11.921658	35.13	4.20 Cr	₹20	21 L	09 Jul 2026	Allotment	1,00,02,000	Insider Trading	—	Equity
13 Jul 2026	Promoter Group	Acquisition	2.270792	4.21	80 L	₹20	4 L	09 Jul 2026	Allotment	12,00,000	Insider Trading	—	Equity
13 Jul 2026	Promoter Group	Acquisition	0.567698	0.35	20 L	₹20	1 L	09 Jul 2026	Allotment	1,00,000	Insider Trading	—	Equity
06 Jul 2026	Promoter	Acquisition	0.35	36.42	0	—	9.50 L	29 May 2026	Conv. of Warrants	87,02,000	SAST	29(2)	—
06 Jul 2026	Promoter	Acquisition	1.47	11.95	0	—	5.60 L	29 May 2026	Conv. of Warrants	28,55,733	SAST	29(2)	—
06 Jul 2026	Promoter	Acquisition	0.35	36.42	0	—	9.50 L	29 May 2026	Conv. of Warrants	87,02,000	SAST	29(2)	—

Novelix Pharmaceuticals Share Price

64.20-1.81 (-2.74%)

+22.15% past 1 Year

Trimurthi Limited is a Public Limited Company having Registered Office situated at Hyderabad, Telangana. The company is into the business of Trading of Pharmaceuticals and related products and is into

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

Amrutha Estates, 6th Floor H. No. 3-6-237/610, Lingapur La Builders Himayath Nagar Hyderabad Telangana PIN: 500029 Tel No: 8977631044 Fax No: 040-24757370 Email: [email protected] Internet: https://novelixpharma.com

Registrars

Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com

Management

Venkateshwarlu Pulluru, Whole Time Director

Janardhan Das Kabra, Non Executive Independent Director

Lakshman Samala, Non Executive Independent Director

Gattu Gnana Prakash, Non Independent & Non Executive Director

Mayuri Baidya, Non Executive Independent Director

Nishita Kalantri, Company Secretary & Compliance Officer

Sridevi Belide, Non Independent & Non Executive Director

Details

BSE 536565

NSE NULL

ISIN INE314I01036